Market cap
$32,284 Mln
Revenue (TTM)
$9,948 Mln
P/E Ratio
38.8
P/B Ratio
1.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 10.42 | 3.42 | -0.49 | -0.08 | -3.19 |
| EBIT | -48.53 | -76.55 | -57.79 | -24.83 | -13.13 |
| Net Profit | -69.48 | -84.64 | -45.44 | -31.58 | -18.67 |
| EPS | -69.55 | -84.93 | -46.13 | -32.49 | -14.64 |
| Book Value | -- | -- | 8.77 | 10.49 | 12.36 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 21.74 | 25.23 | 11.19 | 22.07 | 24.00 |
| Net Margin
| -- | 21.96 | 8.39 | -- | -- |
| Return on equity
| 8.66 | 13.10 | 4.50 | 7.40 | 10.36 |
| Return on Capital
| 6.00 | 8.45 | -- | 5.33 | 7.18 |
| Return on Assets
| 4.99 | 6.79 | 2.47 | 4.50 | 5.95 |
| Debt to Equity (x)
| -- | -- | 0.39 | 0.38 | 0.40 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
--
|
5.33
|
7.18
|
5.51
|
15.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
4.50
Lower than Peers by 14.47
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
4.50
|
7.40
|
10.36
|
8.24
|
25.08
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
2.47
Lower than Peers by 0.38
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
2.47
|
4.50
|
5.95
|
4.52
|
12.58
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
11.19
Lower than Peers by 4.63
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
11.19
|
22.07
|
24.00
|
19.14
|
29.67
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
8.39
Higher than Peers by 0.16
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
8.39
|
13.18
|
16.87
|
11.81
|
28.24
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.49
Lower than Peers by 8.54
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
-0.49
|
0.01
|
-0.02
|
-0.03
|
-0.07
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
-57.79
Lower than Peers by 66.05
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
-57.79
|
-6.77
|
23.39
|
-37.64
|
-12.14
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
-45.44
Lower than Peers by 53.17
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
-45.44
|
-20.76
|
40.57
|
-61.89
|
95.80
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
EPS Growth
-46.13
Lower than Peers by 56.52
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
-46.13
|
-0.21
|
0.40
|
-0.62
|
0.99
|
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
Book Value Growth
4.87
Lower than Peers by 0.00
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
4.87
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.39
Lower than Peers by 0.21
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
0.39
|
0.38
|
0.40
|
0.50
|
0.49
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
0.04
|
0.00
|
0.10
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.87
Higher than Peers by 0.21
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
1.87
|
2.68
|
1.35
|
2.00
|
2.99
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
1.26
Higher than Peers by 0.06
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
1.26
|
2.03
|
0.90
|
1.26
|
2.58
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
4.01
Lower than Peers by 0.76
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
4.01
|
8.80
|
9.28
|
7.62
|
12.24
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
18.95
Lower than Peers by 2.32
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
18.95
|
19.03
|
19.31
|
21.35
|
21.00
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
0.29
Lower than Peers by 0.10
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
0.29
|
0.34
|
0.35
|
0.38
|
0.42
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
--
|
69.54
|
74.91
|
78.66
|
73.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
--
|
291.78
|
394.27
|
279.11
|
216.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
--
|
53.97
|
65.41
|
64.50
|
86.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
--
|
307.35
|
403.77
|
293.26
|
203.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
38.81
Higher than Peers by 1.49
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
38.81
|
19.96
|
13.69
|
32.47
|
13.20
|
|
Peer Median
|
37.32
|
--
|
--
|
--
|
--
|
Price / Book Value
1.74
Lower than Peers by 6.02
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
1.74
|
1.41
|
1.34
|
2.55
|
3.00
|
|
Peer Median
|
7.75
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
EV/EBITDA
18.60
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
18.60
|
9.34
|
8.88
|
18.51
|
11.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
32,284
Higher than Peers by 29,763
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Biogen (BIIB)
|
32,284
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2,521
|
--
|
--
|
--
|
--
|